| Title |
Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, August 2015
|
| DOI | 10.1007/s00228-015-1908-x |
| Pubmed ID | |
| Authors |
Sanne Verdoorn, Henk-Frans Kwint, Adrianne Faber, Jacobijn Gussekloo, Marcel L Bouvy |
| Abstract |
STOPP and START criteria identify potential inappropriate prescribing and potential prescribing omissions. It is unknown whether STOPP/START criteria identify all drug-related problems. This study aims to determine to what extent STOPP/START correspond to drug-related problems (DRPs) identified during a full clinical medication review. In 13 Dutch community pharmacies, 457 community-dwelling patients aged ≥65 years and using ≥5 drugs, received a full clinical medication review. Community pharmacists identified potential DRPs and recommendations by implicit criteria. After completion, all identified DRPs and recommendations were compared with STOPP and START criteria by investigators. The total number of potential DRPs identified by community pharmacists was 1656 in 457 patients (mean 3.6 per patient). Eighty-one percent of DRPs were not associated with STOPP/START criteria. The percentage of START criteria present in identified DRPs was higher than the percentage of STOPP criteria (13 vs. 5.7 %, p < 0.01). The implementation rate for recommendations associated with STOPP criteria was higher compared to recommendations associated with START criteria (56 vs. 39 %, p < 0.01). Both implementation rates of STOPP and START recommendations were lower compared to recommendations not associated with STOPP/START criteria (66 %, p = 0.047 and p < 0.001, respectively). This study shows that the majority of drug-related problems of community-dwelling older patients was not associated with STOPP/START criteria. These findings suggest that application of STOPP/START criteria in full clinical medication review should preferably be combined with implicit criteria. |
X Demographics
The data shown below were collected from the profiles of 34 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 15% |
| United Kingdom | 3 | 9% |
| Ireland | 2 | 6% |
| El Salvador | 1 | 3% |
| Rwanda | 1 | 3% |
| United States | 1 | 3% |
| Canada | 1 | 3% |
| Australia | 1 | 3% |
| Unknown | 19 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 22 | 65% |
| Practitioners (doctors, other healthcare professionals) | 9 | 26% |
| Scientists | 2 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 2% |
| Spain | 1 | <1% |
| Unknown | 163 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 31 | 19% |
| Student > Master | 25 | 15% |
| Researcher | 21 | 13% |
| Student > Bachelor | 15 | 9% |
| Other | 13 | 8% |
| Other | 31 | 19% |
| Unknown | 31 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 45 | 27% |
| Nursing and Health Professions | 14 | 8% |
| Agricultural and Biological Sciences | 5 | 3% |
| Arts and Humanities | 3 | 2% |
| Other | 10 | 6% |
| Unknown | 38 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2019.
All research outputs
#1,713,467
of 24,838,271 outputs
Outputs from European Journal of Clinical Pharmacology
#95
of 2,702 outputs
Outputs of similar age
#21,867
of 269,645 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#2
of 28 outputs
Altmetric has tracked 24,838,271 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,702 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,645 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.